Quantcast

Latest insulin pump Stories

2011-06-02 03:00:00

WEST CHESTER, Pa., June 2, 2011 - Animas Corporation announced today the receipt of CE Mark approval for Animas® Vibe(TM), the first and only continuous glucose monitoring (CGM)-enabled insulin pump system with Dexcom G4(TM) CGM technology. Animas® Vibe(TM) brings together the unique features of an Animas® insulin pump and the convenience of Dexcom CGM, which is the only sensor approved for up to seven days of wear. To view the...

2011-06-02 00:00:32

The website's new Carb Planning Tool helps people with diabetes estimate their carbohydrate intake, while its new Diabetes Product Directory allows users to learn about currently available diabetes products in numerous categories, plus read user reviews and even rate the products themselves. Mount Laurel, NJ (PRWEB) June 01, 2011 DiabetesCare.net, the fastest growing, advertising-free diabetes resource on the Internet, has launched its latest free-to-use resources for people with diabetes:...

2011-05-17 07:45:00

SUNNYVALE, Calif., May 17, 2011 /PRNewswire/ -- Asante Solutions, Inc. (Asante), a medical device company focused on diabetes care, announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the company's Pearl Insulin Pump. Last month, the Pearl also received the CE Mark, a European proof of conformity that certifies the product meets EU safety, health and environmental requirements. "We are pleased to accomplish these important regulatory milestones, and we are...

2011-05-11 08:00:00

WEST CHESTER, Pa., May 11, 2011 /PRNewswire/ -- Animas Corporation and LifeScan, Inc., both members of the Johnson & Johnson Family of Diabetes Companies, today announced plans to further build upon their existing collaborative efforts to co-develop and market innovative new products and tools for people living with diabetes. The increased collaboration also will include more closely aligning their commercial organizations to actively co-promote their product offerings, such as the...

2011-05-10 07:00:00

NEW YORK and SAN DIEGO, May 10, 2011 /PRNewswire/ -- The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced today that they have entered into a research collaboration agreement to provide financial support for a series of clinical studies to investigate the feasibility of mixing pramlintide, an analog of the human hormone amylin, with insulin to treat type 1 diabetes. Pramlintide, marketed by Amylin as SYMLIN®...

2011-05-09 08:00:00

MILPITAS, Calif., May 9, 2011 /PRNewswire/ -- LifeScan, Inc., makers of the top-selling OneTouch® Brand of Blood Glucose Monitoring Systems for people with diabetes, has fulfilled the terms of its exclusive, three-year agreement to provide Medtronic customers in the U.S. with the OneTouch® UltraLink® Blood Glucose Meter that wirelessly transmits glucose values to Medtronic MiniMed Paradigm®( )insulin pumps and...

2011-05-06 06:30:00

SAN DIEGO, May 6, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today reported financial results for the first quarter 2011. (Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO) "The faster insulin absorption and shorter duration of action observed in our first ultrafast insulin pump study is...

2011-04-23 00:00:30

Just released application for Android mobile devices eliminates risky calculation guess work for 250 million diabetics "“ DiabeticSystem.com Saint Paul, MN (PRWEB) April 22, 2011 This week HealthVision Solutions, LLC released its patent-pending HVS Diabetic Management System, a new smart phone application and database search engine that helps diabetics make critical calculations when managing their blood sugar & insulin levels. Up until now the world's 250 million people with...

2011-04-15 14:20:05

Research: Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomized controlled studies Two small randomised trials published on bmj.com today suggest that closed loop insulin delivery (also known as an artificial pancreas) may improve overnight blood glucose control and reduce the risk of nocturnal hypoglycaemia (a sudden drop in blood glucose levels during the night) in adults with type 1 diabetes. The number of people with type 1...

2011-04-14 19:30:00

SAN DIEGO, April 14, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) today announced results from a study in type 1 diabetes patients who receive their insulin treatment with a pump demonstrating that Aspart-PH20, a formulation of Halozyme's rHuPH20 (recombinant human hyaluronidase) with the active ingredient in NovoLog®, accelerates insulin absorption and shortened its duration of action. These preliminary results represent the first reported experience...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related